Bionik Laboratories to Use Machine Learning and Analytics to Improve Neurological Rehabilitation

Bionik Laboratories Corp. (OTCQX:BNKL) will be working with IBM to develop a unique analytics system and apply sophisticated machine learning algorithms to improve the outcomes of neurological rehabilitation.
According to the company’s press release:

ARKE is Bionik’s proprietary robotic lower-body exoskeleton device that is designed to allow paraplegics as well as other wheelchair users the ability to rehabilitate through walking and other motion. Use of IBM’s cognitive computing infrastructure would enable access to the exoskeleton’s performance, patient data, and results of ARKE rehabilitation from multiple sites, including rehabilitation centers, physicians’ offices, physiotherapists’ offices, patients’ homes, research centers or any other location at any time. Phase one of the IBM development project for ARKE is expected to be completed in 2016. Phase one will include the full backend required to capture the information needed for future use.

Michal Prywata, Co-Founder and Chief Operating Officer of Bionik, stated:

This collaboration is the genesis of a meeting nearly a year ago where we discussed the universal importance of big data. During our follow-on conversations we began to realize synergies and started to discuss potential ways in which we could work together to develop an intelligent analytics platform for ARKE.